Global Interventional Radiology Products Market to reach USD 15 billion by 2027.Global Interventional Radiology Products Market is valued approximately at USD 9.6 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.6% over the forecast period 2021-2027. Interventional radiology is the practice of diagnosing and treating illnesses using minimally invasive imaging-guided techniques. The field of interventional radiology has grown significantly as a result of its wide range of applications in the diagnosis and treatment of a variety of illnesses, as well as technical developments. The interventional radiology products market are driven by factors such as growing geriatric population and rising prevalence of chronic diseases. For instance, as per Statista, according to the World Health Organization, diabetes claimed the lives of around 1.5 million people worldwide in 2019. According to forecasts, there will be 700 million diabetics globally by 2045. Furthermore, increasing demand for minimally invasive procedures boost the market growth further. for instance, The American Institute of Minimally Invasive Surgical (AIMS) states that the advantages of minimally invasive treatments over traditional open surgery techniques include increased safety, reduced scarring, faster recovery, and shorter hospital stays. The utilization of technologically advanced products and procedures is expanding the application areas of minimally invasive treatments, particularly for the treatment of CVD, cancer, and peripheral artery disease (PAD). However, availability of effective conventional first-level treatments, may impede market growth over the forecast period of 2021-2027.

North America, Europe, Asia Pacific, and the Rest of the World are the regions that interventional radiology products are sold. North America, followed by Europe, was the largest regional segment of the overall market in 2020. The high incidence of chronic illnesses, expanding geriatric population, increasing acceptance of minimally invasive treatments, and the presence of important companies in the region all contribute to the region's large market share.

Major market player included in this report are:
Boston Scientific Corporation
B. Braun Melsungen AG
Biosensors International Group, Ltd.
Terumo Medical Corporation
Cook Medical
Teleflex Incorporated
Palex Medical SA
Cardionovum GmbH
Penumbra, Inc.
ENDOCOR GmbH



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Catheters
Stents
Inferior Vena Cava (IVC) Filters
Hemodynamic Flow Alteration Devices
Angioplasty Balloons
Other
By Procedure:
Angioplasty
Angiography
Embolization
Thrombolysis
Biopsy & Drainage
Other
By Application:
Cardiology
Urology & Nephrology
Oncology
Gastroenterology
Neurology
Other
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Interventional Radiology Products Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors